Inhibitory Antibodies
-
F1017 Anti-SpA Antibody (Omodenbamab)Summary: Anti-SpA Antibody (Omodenbamab) -
F2031 Anti-ACVR2B Antibody (Bimagrumab)Summary: Anti-ACVR2B Antibody (Bimagrumab) -
F1366 Anti-MUC1 Antibody (Gatipotuzumab)Summary: Anti-MUC1 Antibody (Gatipotuzumab) -
F1524 Anti-Tau Antibody (Semorinemab)Summary: Anti-Tau Antibody (Semorinemab) -
F2098 Anti-TNF-α Antibody (Etanercept)Summary: Anti-TNF-α Antibody (Etanercept) -
F1722 Anti-PRLR/Prolactin Receptor Antibody (BAY 1158061)Summary: Anti-PRLR/Prolactin Receptor Antibody (BAY 1158061) -
BA2316 InotuzumabSummary: Inotuzumab (HumanizedAnti-CD22RecombinantAntibody) is humanized, κ-antibody targeted to humans. -
F1001 Anti-CD4 Antibody (Ibalizumab)Summary: Anti-CD4 Antibody (Ibalizumab) -
F1002 Anti-FOLR1/FRA Antibody (Farletuzumab)Summary: Anti-FOLR1/FRA Antibody (Farletuzumab) -
F1003 Anti-CD4 Antibody (Semzuvolimab)Summary: Anti-CD4 Antibody (Semzuvolimab)
